Scarica l'app Stockscreener
12.78
0.12%
-0.015
Dopo l'orario di chiusura:
12.78
0.005
+0.04%
Angiodynamic Inc Borsa (ANGO) Ultime notizie
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
AngioDynamics Inc (ANGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AngioDynamics wins FDA okay to test NanoKnife in BPH patients - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics Inc (ANGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AngioDynamics Inc (ANGO) Institutional Confidence - TradingKey
AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026Slideshow - Seeking Alpha
ANGO News | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - AboutLawsuits.com
ANGO Technical Analysis & Stock Price Forecast - Intellectia AI
ANGO Stock Price, Quote & Chart | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Webcast set for AngioDynamics talk at Goldman Sachs health event - Stock Titan
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Yahoo Finance
Point72 (ANGO) reports 3.18M shares, 7.7% stake via Point72 Associates - Stock Titan
Prostate cancer trial sees 0 new failures with NanoKnife at 2 years - Stock Titan
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet - Yahoo Finance
AngioDynamics alleges patent infringement by E2 over clot removal technology - MassDevice
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
Fair Value Assessment | AngioDynamics Inc. posts 117.8% EPS surprise beating loss estimatesEarnings Risk - Cổng thông tin điện tử tỉnh Tây Ninh
AngioDynamics files patent lawsuit against Endovascular Engineering - Investing.com
ANGO (AngioDynamics Inc.) notches massive Q1 2026 EPS beat, but shares fall 1.24 percent on slight year over year revenue decline.Social Trade Signals - Xã Thanh Hà
AngioDynamics (ANGO) Upgraded to Buy: Here's Why - Yahoo Finance
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down - TradingView
AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview - Minichart
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2026 Earnings Call Transcript - Insider Monkey
AngioDynamics (NASDAQ: ANGO) Q3 2026 revenue up 9% while net loss grows - Stock Titan
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-04-02 - Seeking Alpha
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance - ChartMill
ANGIODYNAMICS ($ANGO) Releases Q3 2026 Earnings | ANGO Stock News - Quiver Quantitative
AngioDynamics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
AngioDynamics investors can watch Needham conference webcast April 14 - Stock Titan
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking A 71.55% Potential Upside - DirectorsTalk Interviews
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics, Inc. (ANGO) Stock Analysis: A Potential 81.88% Upside For Investors - DirectorsTalk Interviews
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
Bard And AngioDynamics Resolve 11-Year Patent Dispute - Law360
AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
AngioDynamics, Inc. (ANGO) Investor Outlook: An 80% Upside Potential Amid Strategic Healthcare Innovations - DirectorsTalk Interviews
AngioDynamics CEO Details Portfolio Shift as Auryon, AlphaVac and NanoKnife Fuel Growth at Conference - Yahoo Finance
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates - Finviz
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
0.22%
0.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):